The bill amends the Public Health Code by updating sections 7340 and 7340a, which regulate the sale of products containing ephedrine or pseudoephedrine. It allows individuals to offer these products for retail sale but mandates that they ensure delivery directly to the purchaser and comply with federal laws. The bill also introduces a new requirement for manufacturers to participate in a national, real-time logging system for tracking retail sales of these substances starting June 1, 2026. Additionally, it specifies that violations of these regulations can result in felony charges with penalties of up to four years in prison or fines of up to $5,000.

In section 7340a, the bill clarifies that retailers must electronically submit sales information to the National Precursor Log Exchange (NPLEx) without incurring fees. It also establishes that the NPLEx must provide real-time access to law enforcement and generate alerts for prohibited purchases. The bill includes provisions for maintaining records in case of system failures and ensures that individuals are not liable for damages resulting from compliance failures unless directly caused. Overall, the amendments aim to enhance the regulation of substances that can be misused for illegal drug production while providing necessary protections for retailers and consumers.

Statutes affected:
House Introduced Bill: 333.7340